Recurrence of Renal Cell Carcinoma: Case Report
DOI:
https://doi.org/10.20453/rmh.v37i1.6463Keywords:
renal cell carcinoma, recurrence, therapeuticsAbstract
Up to 40% of patients with Stage II-III renal carcinoma eventually suffer a recurrence despite radical nephrectomy (RN). We present the case of a 40-year-old male with a diagnosis of clear cell carcinoma, who underwent RN with regional lymphadenectomy. He was on follow-up for 3 years with no evidence of metastasis. He came for consultation 19 years later, referring to pain in the left hypochondrium. Abdominal multislice CT scan showed a tumor in the left renal fossa. On positron emission tomography (PET/CT), a retroperitoneal tumor with active disease was confirmed, so resection was performed. This case emphasizes the need for long-term rigorous follow-up.
Downloads
References
Urushibara M, Nagata M, Okumura T, et al. Bladder metastasis with additional metastases in multiple other organs 4 years after radical nephrectomy for clear cell renal cell carcinoma: a case report and review of the literature. J Med Case Reports. 2022;16:131. doi:10.1186/s13256-022-03368-w
Motzer RJ, Jonasch E, Agarwal N, et al. Kidney cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2022;20(1):71-90. doi:10.6004/jnccn.2022.0001
Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209-249. doi:10.3322/caac.21660
Ferlay J, Ervik M, Lam F, et al. Global Cancer Observatory: Cancer Today: South America [Internet]. International Agency for Research on Cancer; 2024. Disponible en: https://gco.iarc.who.int/media/globocan/factsheets/populations/931-south-america-fact-sheet.pdf
Ferlay J, Ervik M, Lam F, et al. Global Cancer Observatory: Cancer Today: Peru [Internet]. International Agency for Research on Cancer; 2024. Disponible en: https://gco.iarc.who.int/media/globocan/factsheets/populations/604-peru-fact-sheet.pdf
Chin AI, Lam JS, Figlin RA, et al. Surveillance strategies for renal cell carcinoma patients following nephrectomy. Rev Urol [Internet] 2006 [citado en febrero de 2025];8(1):1-7. Disponible en: https://pmc.ncbi.nlm.nih.gov/articles/PMC1471767/
Dabestani S, Thorstenson A, Lindblad P, et al. Renal cell carcinoma recurrences and metastases in primary non-metastatic patients: a population-based study. World J Urol. 2016;34:1081-6. doi:10.1007/s00345-016-1773-y
Newmark JR, Newmark GM, Epstein JI, et al. Solitary late recurrence of renal cell carcinoma. Urology. 1994;43(5):725-8. doi:10.1016/0090-4295(94)90199-6
Romeo A, Garcia P, Jurado AM, et al. Renal fossa recurrence after radical nephrectomy: current management, and oncological outcomes. Urol Oncol. 2020;38(2):42.e7-12. doi:10.1016/j.urolonc.2019.10.004
Markinez I, Jiménez R, Ruiz I, et al. Metástasis pancreáticas por carcinoma renal. Nuestra casuística y revisión de la literatura. Cir Esp. 2013;91(2):90-5. doi:10.1016/j.ciresp.2012.07.007
Thomas AZ, Adibi M, Borregales LD, et al. Surgical management of local retroperitoneal recurrence of renal cell carcinoma after radical nephrectomy. J Urol. 2015;194(2):316-22. doi:10.1016/j.juro.2015.02.2943
Bruno JJ II, Snyder ME, Motzer RJ, et al. Renal cell carcinoma local recurrences: impact of surgical treatment and concomitant metastasis on survival. BJU Int. 2006;97(5):933-8. doi:10.1111/j.1464-410X.2006.06076.x
Marconi L, Kuusk T, Capitanio U, et al. Local treatment of recurrent renal cell carcinoma may have a significant survival effect across all risk-of-recurrence groups. Eur Urol Open Sci. 2023;47:65-72. doi:10.1016/j.euros.2022.11.008
Huang J, Wang Y, Zhang C, et al. Surgical management and oncologic outcomes for local retroperitoneal recurrence of renal cell carcinoma after radical nephrectomy. Clin Genitourin Cancer. 2023;21(2):315.e1-7. doi:10.1016/j.clgc.2022.10.010
Psutka SP, Heidenreich M, Boorjian SA, et al. Renal fossa recurrence after nephrectomy for renal cell carcinoma: prognostic features and oncological outcomes. BJU Int. 2016;119(1):116-27. doi:10.1111/bju.13620
Ljungberg B, Albiges L, Abu-Ghanem Y, et al. European Association of Urology guidelines on renal cell carcinoma: the 2022 update. Eur Urol. 2022;82(4):399-410. doi:10.1016/j.eururo.2022.03.006
Escudier B, Porta C, Schmidinger M, et al. Renal cell carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2019;30(5):706-20. doi:10.1093/annonc/mdz056
Wei Y, Yuan J, Ren S, et al. Treatment of the recurrence after radical resection of clear cell renal cell carcinoma. Asian J Surg. 2023;46(2):1149-50. doi:10.1016/j.asjsur.2022.08.019
Itano NB, Blute ML, Spotts B, et al. Outcome of isolated renal cell carcinoma fossa recurrence after nephrectomy. J Urol. 2000;164(2):322-5. doi:10.1016/S0022-5347(05)67350-8
Sandhu SS, Symes A, A’Hern R, et al. Surgical excision of isolated renal-bed recurrence after radical nephrectomy for renal cell carcinoma. BJU Int. 2005;95(4):522-5. doi:10.1111/j.1464-410X.2005.05331.x
Master VA, Gottschalk AR, Kane C, et al. Management of isolated renal fossa recurrence following radical nephrectomy. J Urol. 2005;174(2):473-7. doi:10.1097/01.ju.0000165574.62188.d0
Johnson A, Sudarshan S, Liu J, et al. Feasibility and outcomes of repeat partial nephrectomy. J Urol. 2008;180(1):89-93. doi:10.1016/j.juro.2008.03.030
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Luis Rafael Zegarra Montes, Mario Eduardo Garrido Toribio, Jose Leonardo Medina Holguín, Andrea Valdez, Estefano M Benites
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors assign their rights to the RMH so that may disseminate the article through the means at their disposal. The journal will provide forms of affidavit of authorship and authorization for the publication of the article, which shall be submitted with the manuscript. Authors retain the right to share, copy, distribute, perform and publicly communicate their article, or part of it, mentioning the original publication in the journal.
